GENEVA, July 1 -- BIOCRYST PHARMACEUTICALS, INC. filed a patent application (US2025/053503) for “BIFUNCTIONAL THERAPEUTIC ANTIBODY TARGETING THE COMPLEMENT CASCADE”. With publication no. WO/2026/096881, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....